Mono- and bicyclic DNA gyrase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548131, 544138, 544310, 5462724, 5462727, 5462681, 5462691, A61K 3141, C07D29108

Patent

active

056657463

ABSTRACT:
The present invention relates to a compound of the formula ##STR1## wherein X.sup.1, R.sup.1, R.sup.2, OP, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.0 are as described herein, and their pharmaceutically acceptable salts thereof carrying an acidic andr basic substituent.
The compound of formula I as well as their pharmaceutically acceptable salts inhibit DNA gyrase activity in bacteria and possess antibiotic, especially antibacterial activity against microorganisms and can be used in the control or prevention of infectious diseases.

REFERENCES:
patent: 5294609 (1994-03-01), Arisawa et al.
Goetschi, E., et al., Pharmac. Ther., 60:367-380 (1993).
Goetschi, E., et al., Chemical Abstract 121:124616 (1993).
Kamiyama, Tsutomu, et al., The Journal of Antibiotics, 47(1):37-45 (1993).
Kamiyama, Tsutomu, et al., Chemical Abstract 120:212154z (1994).
The Merck Manual, 15th ed. (1987), Berkow, M.D., editor, p. 46.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mono- and bicyclic DNA gyrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mono- and bicyclic DNA gyrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mono- and bicyclic DNA gyrase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-70437

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.